2025 · 4th Quarter (Oct 1 - Dec 31)

ASTCT

Filed by SMITHBUCKLIN CORPORATION.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: $70,000.00
Expenses: Not reported
Registrant: SMITHBUCKLIN CORPORATION
Client: ASTCT
Filing UUID: 39f0e17d-f1f4-41dd-ba4f-707a62f87442
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Labor-HHS Appropriations Billing and Coding CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients Patient-Care Episode Financial Toxicity NIH Funding Cancer Moonshot H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act

Literal federal measure citations: H.R. 1509, S. 752, H.R. 2491, S. 1227, H.R. 5160, H.R.1262, S.932

MMM · Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Literal federal measure citations: H.R. 1509, S. 752, H.R. 2491, S. 1227

MED · Medical/Disease Research/Clinical Labs

- Labor-HHS Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement - Cancer Moonshot - NIH Funding

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.